Concepedia

Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study.

Stefan Lyer, Rainer Tietze, Roland Jurgons, Tobias Struffert, Tobias Engelhorn, Eveline Schreiber, Arnd Dörfler, Christoph Alexiou

PubMed · 2010 · 49 citations · 10 references

Abstract

MDT leads to significant tumour size reductions within several weeks after a single administration of chemotherapy. In this pilot study, FD-CT offered an excellent possibility to monitor the vascularisation and the size of the tumours before and after MDT.

References

10

Magnetic nanoparticles for drug delivery

Jon Dobson · Drug Development Research · 2006 · 874 citations · Full text

, , +18

Locoregional cancer treatment with magnetic drug targeting.

Christoph Alexiou, W. Arnold, Robert J. Klein et al. · PubMed · 2000 · 868 citations

, , +14

Targeting cancer cells: magnetic nanoparticles as drug carriers

Christoph Alexiou, Roswitha J. Schmid, Roland Jurgons et al. · European Biophysics Journal · 2006 · 357 citations

, , +6

Magnetic Drug Targeting--Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment

Ernst Huenges, F. Parak, Christoph Alexiou et al. · Journal of drug targeting · 2003 · 239 citations

, , +18

A High Field Gradient Magnet for Magnetic Drug Targeting

Christoph Alexiou, D. Diehl, Peter Henninger et al. · IEEE Transactions on Applied Superconductivity · 2006 · 148 citations

, , +22